Smoking and Disease Risk: Cardiovascular and Cancer Links
This paper analyzes the relationship between smoking and increased disease risk, focusing on cardiovascular disease and cancer. It establishes current smoking prevalence among U.S. adolescents and adults, explores the biochemical mechanisms linking smoking to CVD (including oxidative stress and inflammation), and reviews cancer risks from tobacco's 69 carcinogens. The paper then compares smoking rates and disease mortality across three major U.S. metropolitan areas—Massachusetts, New York City, and Los Angeles—to assess geographic variation. While smoking rates have declined, the paper concludes that 30–60 million Americans face substantially elevated CVD and cancer risk, justifying continued public health investment in smoking cessation programs.
- Smoking Prevalence in the United States: Current rates among youth and adults nationwide
- Smoking and the Risk of Cardiovascular Disease: CVD mechanisms: ROS, inflammation, arterial damage
- Smoking and Cancer Risk: 69 carcinogens and relative risk by gender
- Geographic Variation in Smoking and Disease: Rates in Massachusetts, NYC, and Los Angeles
- Discussion and Public Health Implications: Policy priorities and remaining disease burden
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounded epidemiology: Opens with concrete prevalence data (6% of high school students, 19% of adults), establishing the scope of the public health problem and justifying why the topic matters.
- Mechanistic depth: Moves beyond correlation to explain why smoking causes disease—reactive oxygen species, endothelial dysfunction, and carcinogen exposure—bridging population statistics with pathophysiology.
- Geographic specificity: Rather than treating smoking risk as uniform, the paper compares Massachusetts, New York City, and Los Angeles, revealing that smoking rates alone do not predict CVD mortality, adding nuance to the discussion.
- Quantified risk: Uses clear relative risk figures (25–26 fold for cancer, 2–4 fold for CVD) to communicate severity in language stakeholders understand.
Key academic technique demonstrated
The paper demonstrates synthesis of epidemiological evidence with mechanistic research. Rather than listing isolated studies, it weaves population-level data (CDC prevalence statistics), molecular mechanisms (ROS-induced oxidative stress), and clinical outcomes (carotid intima-media thickness in youth) into a coherent causal narrative. This approach—connecting "how many" with "how it happens"—is characteristic of public health and clinical review writing.
Structure breakdown
The paper follows a standard public health essay structure: (1) establish prevalence and burden (introduction), (2) explain disease-specific causal pathways (CVD and cancer), (3) apply findings to real-world variation (geographic analysis), and (4) conclude with policy implications. Each section deepens the reader's understanding incrementally, from "smoking is common" to "here's why it matters" to "here's where it matters most."
Smoking Prevalence in the United States
In 2015, the U.S. Census Bureau (2014) projected that 17 million adolescents between the ages of 14 and 17 would be residing in the United States, compared to 250 million adults aged 18 and over. The rate of tobacco use among high school students in the U.S. is estimated at 6 percent based on data from the U.S. Centers for Disease Control and Prevention (CDC, 2014). This rate reflects students who smoked cigarettes at least 20 days out of the last 30 days; therefore, approximately one million high school students are frequent tobacco users. The percentage increases substantially when less frequent use is considered, including cigars and smokeless tobacco.
By comparison, nearly 19 percent of all adults aged 18 and over were current smokers in 2010, with slightly higher concentrations of smokers in the Midwest and South (CDC, 2013). This translates into almost 50 million smokers in the U.S. today. Tobacco use is a significant public health concern because researchers have demonstrated that tobacco users face increased risk of cardiovascular disease, cancer, lung disease, and reproductive problems (CDC, 2013). The direct medical costs attributed to smoking total $96 billion, with an additional $97 billion in lost productivity. This essay examines the prevalence of smoking among youth and adults, in addition to the smoking-related causes of heart disease and cancer.
Smoking and the Risk of Cardiovascular Disease
Worldwide, cardiovascular disease (CVD) accounts for 30 to 40 percent of all deaths, of which 10 percent has been attributed to tobacco use (Kim, Han, & Lee, 2014). Among smokers, 31 percent of all smoking-related deaths are caused by CVD. The threat of stroke and coronary heart disease increases by 2- to 4-fold in smokers, demonstrating a close, strong relationship between smoking and CVD prevalence.
The etiology of CVD risk from smoking is complex and involves multiple mechanisms, including endothelial dysfunction, induction of a prothrombic state, chronic inflammation, changes in lipid metabolism, and hypoxia (Kim, Han, & Lee, 2014). Among the most well-studied causes is the induction of reactive oxygen species (ROS), which leads to oxidative stress, reduced nitric oxide bioavailability, induced prothrombic state, inflammation, and lipoprotein oxidation. Although cigarette smoke contains ROS species, these tend to be short-lived; their overall impact is minor by comparison to the ROS induced within the body.
Smoking in childhood and adolescence increases lifelong smoking risk, largely due to development of physical dependence on nicotine (Dratva et al., 2013). While most research on smoking-related disease risk has focused on adult populations, a recent study examined predictors of CVD risk in children, adolescents, and young adults between the ages of 8 and 20. An early indicator of atherosclerosis—the thickness of the carotid artery intima media—was found to be significantly increased in smokers compared to non-smokers within this age group (Dratva et al., 2013). This finding is important because CVD risk begins in childhood, partly due to arterial changes that occur early in life. Based on these findings, youth who begin smoking substantially increase their risk of CVD development later in life.
Smoking and Cancer Risk
Lung cancer was linked to smoking more than 50 years ago (Caffrey, 2014). Since then, numerous other cancers have been linked to smoking, including colorectal and breast cancer. Recent evidence supports smoking cessation as at least as effective as the best chemotherapy drugs in bringing about cancer remission. Given that chemotherapy treatment can cost in excess of $100,000 per patient, smoking cessation represents a significant economic advantage.
The risk of cancer from smoking stems from tobacco smoke containing 69 different carcinogens. Manufacturing changes made decades ago have increased cancer risk. For women, the relative risk of lung cancer rose to 25.66 in 2010. In men, the relative risk was slightly lower for the same year, at 24.97. This translates into a 26- and 25-fold increase in cancer risk for women and men, respectively, due to smoking. Smoking also increases the risk of other cancers, including oropharyngeal, esophageal, stomach, pancreatic, laryngeal, tracheal, cervical, urinary, renal, bladder, and leukemia (Baliunas et al., 2007).
Always verify citation format against your institution’s current style guide requirements.